lo g2 c f t ite r dupilumab amphotericin ambisome fluconazole posaconazole immunomodulators antifungals (Gilead Sciences)
97
Structured Review
Gilead Sciences
lo g2 c f t ite r dupilumab amphotericin ambisome fluconazole posaconazole immunomodulators antifungals
Lo G2 C F T Ite R Dupilumab Amphotericin Ambisome Fluconazole Posaconazole Immunomodulators Antifungals, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 97/100, based on 2955 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/immunomodulation/AmBisome/pm41778809-196-54-63
Average 97 stars, based on 2955 article reviews
Lo G2 C F T Ite R Dupilumab Amphotericin Ambisome Fluconazole Posaconazole Immunomodulators Antifungals, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 97/100, based on 2955 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/immunomodulation/AmBisome/pm41778809-196-54-63
Average 97 stars, based on 2955 article reviews
lo g2 c f t ite r dupilumab amphotericin ambisome fluconazole posaconazole immunomodulators antifungals - by Bioz Stars,
2026-10
97/100 stars
Images
Related Articles
other:Article Title: Exploring the room for repurposed hydroxychloroquine to impede COVID-19: toxicities and multipronged combination approaches with pharmaceutical insights. Article Snippet: To cite this article: Ankit Jain, Shiv Kumar Prajapati, Madhavi Tripathi, Ashok M. Raichur & Jagat R. Kanwar (2021): Exploring the room for repurposed hydroxychloroquine to impede COVID-19: toxicities and multipronged combination approaches with pharmaceutical insights, Expert Review of Clinical Pharmacology, DOI: 10.1080/17512433.2021.1909473 To link to this article: https://doi.org/10.1080/17512433.2021.1909473. Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=ierj20 Expert Review of Clinical Pharmacology ISSN: (Print) (Online) Journal homepage: https://www.tandfonline.com/loi/ierj20 Exploring the room for repurposed hydroxychloroquine to impede COVID-19: toxicities and multipronged combination approaches with pharmaceutical insights Ankit Jain, Shiv Kumar Prajapati, Madhavi Tripathi, Ashok M. Raichur & Jagat R. Kanwar To cite this article: Ankit Jain, Shiv Kumar Prajapati, Madhavi Tripathi, Ashok M. Raichur & Jagat R. Kanwar (2021): Exploring the room for repurposed hydroxychloroquine to impede COVID-19: toxicities and multipronged combination approaches with pharmaceutical insights, Expert Review of Clinical Pharmacology, DOI: 10.1080/17512433.2021.1909473 To link to this article: https://doi.org/10.1080/17512433.2021.1909473 Accepted author version posted online: 26 Mar 2021.. Submit your article to this journal Article views: 18 View related articles View Crossmark data 1 Publisher: Taylor & Francis & Informa UK Limited, trading as Taylor & Francis Group Journal: Expert Review of Clinical Pharmacology DOI: 10.1080/17512433.2021.1909473 Exploring the room for repurposed hydroxychloroquine to impede COVID-19: toxicities and multipronged combination approaches with pharmaceutical insights Ankit Jain1, Shiv Kumar Prajapati2, Madhavi Tripathi1, Ashok M. Raichur1 and Jagat R. Kanwar3 1Department of Materials Engineering, Indian Institute of Science, Bangalore – 560012, Karnataka, India; 2Department of Pharmaceutical Sciences, Bhagyoday Tirth Pharmacy College, Sagar – 470002, Madhya Pradesh, India; 3Department of Biochemistry, All India Institute of Medical Sciences (AIIMS), Bilaspur, HP- - 174001, India |